Table of Contents
- Chapter One: Executive Summary
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting Market
- Competitor Analysis
- Chapter Two: Introduction
- Structure and Function of the Skin
- Epidermis
- Dermis
- Subcutaneous Tissue
- Epidermal Appendages
- Functions of the Skin
- Effects of Aging on the Skin
- Dermatological Conditions and Treatment
- Pharmacokinetics
- Drug Absorption
- Distribution
- Bioavailability
- Drug Delivery Methods
- Demographics of Skin Disorders, Incidence, and Prevalence
- Chapter Three: Issues and Trends
- Cosmetic Dermatologists
- Medicare Reimbursement
- Melanoma Survival Rates Falter
- New Filler Options
- A Confusing Industry
- Genetic Link to Psoriasis
- Biologic Dermatology
- Rx-to-OTC Switches
- Cosmeceuticals
- Antioxidants
- Polypeptides
- Teledermatology
- Reimbursement Issues
- Laser Therapy
- Narrowband Ultraviolet B
- Photodynamic Therapy
- Importance of Drug Delivery
- Chapter Four: Prescription Antiacne and Rosacea Drugs
- Description of Disorders
- Description of Products
- Benzoyl Peroxide
- Description of Products
- Current Suppliers
- Retinoids
- Topical Formulations
- All-trans Retinoic Acid (Tretinoin)
- Adapalene
- Tazarotene
- Systemic Formulations
- Current Suppliers
- Antibiotics
- Description of Products
- Azelaic Acid
- Clindamycin
- Erythromycin
- Metronidazole
- Sodium Sulfacetamide
- Current Suppliers
- Oral Contraceptives
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
- Chapter Five: Prescription Antiaging and Photodamage Drugs
- Overview
- Description of Products
- Keratolytics
- Moisturizers
- Retinoids
- Sunscreens
- Other Agents
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
- Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Overview
- Description of Products
- Topical Corticosteroids
- Systemic Corticosteroids
- Other Products
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
- Chapter Seven: Prescription Antifungal Drugs
- Overview
- Description of Products
- Systemic Formulations
- Terbinafine
- Itraconazole
- Fluconazole
- Griseofulvin
- Ketoconazole
- Current Suppliers
- Topical Formulations
- Polyenes
- Azoles
- Miconazole
- Clotrimazole
- Ketoconazole
- Oxiconazole
- Econazole
- Sulconazole
- Allylamines and Benzylamines
- Naftifine
- Terbinafine
- Butenafine
- Other Topical Formulations
- Current Suppliers
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
- Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Overview
- Description of Products
- Antiandrogens
- Androgen Inhibitors
- Oral Contraceptives
- Other Treatments
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
- Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Overview
- Description of Products
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
- Chapter Ten: Prescription Psoriasis Drugs
- Overview
- Description of Products
- Topical Psoriasis Products
- Anthralin
- Coal Tar
- Methoxsalen
- Second-generation Retinoids
- Tazarotene
- Topical Vitamin D
- Vitamin D Analogs
- Vanos
- Systemic Psoriasis Preparations
- Betamethasone
- Cortisone Acetate
- Cyclosporine
- Hydrocortisone
- Methotrexate
- Olopatadine Hydrochloride
- Tacrolimus
- Light Therapy
- Biologics
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Competitive Analysis
- Chapter Eleven: Prescription Skin Cancer Drugs
- Overview
- Nonmelanoma Skin Cancers
- Actinic Keratoses
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Cutaneous T-cell Lymphoma
- Dysplastic Nevus Syndrome
- Malignant Melanoma
- Description of Products
- 5-Fluorouracil
- Mechlorethamine/Nitrogen Mustard
- Carmustine/BCNU (Topical)
- Vinblastine (Intralesional) and Others
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
- Chapter Twelve: Miscellaneous Skin Disorder Drugs--Antivirals and
Antiparasitics
- Overview
- Antivirals
- Antiparasitics
- Description of Products
- Topical Antivirals
- Antiviral Drugs
- Immunoenhancing Drugs
- Current Suppliers
- Antiparasitic Agents
- Current Suppliers
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
- Chapter Thirteen: World Market Summary
- Overview
- Total Market Size and Forecast
- Market and Competitive Analysis
- Chapter Fourteen: Corporate Profiles
- Allergan Inc.
- Barrier Therapeutics, Inc
- Bayer AG
- Bertek Pharmaceuticals, Inc.
- Bristol-Myers Squibb
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Inamed Corporation
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological,
- Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- SkinMedica
- Valeant Pharmaceuticals, Inc.
- Appendix: Company Directory
- List of Exhibits
- Chapter One: Executive Summary
- Table 1-1: The Global Market for Prescription Dermatological Drugs 2000,
2005, and 2010
- Figure 1-1: The Global Market for Prescription Dermatological Drugs
2000, 2005, and 2010
- Chapter Two: Introduction
- Table 2-1: Common Bases for Topical Dermatological Medications
- Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic
Conditions
- Chapter Three: Issues and Trends
- Table 3-1: Selected Dermatological Rx-to-OTC Switches
- Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC
Switches
- Chapter Four: Prescription Antiacne and Rosacea Drugs
- Table 4-1: Common Benzoyl Peroxide Formulations
- Table 4-2: Common Retinoid Formulations
- Table 4-3: Common Antibiotic Formulations
- Table 4-4: Common Oral Contraceptive Formulations
- Table 4-5: Prescription Acne and Rosacea Formulations in Development
- Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by
Type 2000-2010
- Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs
Revenues by Type 1998-2008
- Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs
Share by Type 2005
- Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs
Share by Type 2010
- Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs
by Geographical Region 2000-2010
- Figure 4-4: The Global Market for Prescription Antiacne and Rosacea
Drugs Revenues by Geographical Region 2000-2010
- Figure 4-5: The Global Market for Prescription Antiacne and Rosacea
Drugs Share by Geographical Region 2005
- Figure 4-6: The Global Market for Prescription Antiacne and Rosacea
Drugs Share by Geographical Region 2010
- Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs
Revenues and Market Share by Supplier 2005
- Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by
Leading Supplier 2005
- Chapter Five: Prescription Antiaging and Photodamage Drugs
- Table 5-1: Common Prescription Keratolytic Formulations
- Table 5-2: Occlusive Moisturizers--Categories of Ingredients
- Table 5-3: Common Prescription Moisturizers
- Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
- Table 5-5: Common Prescription Sunscreens
- Table 5-6: Other Prescription Antiaging and Photodamage Products
- Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type
2000-2010
- Figure 5-1: The Global Market for Antiaging and Photodamage Drugs
Revenues by Type 2000-2010
- Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share
by Type 2005
- Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share
by Type 2010
- Table 5-10: The Global Market for Prescription Antiaging and Photodamage
Drugs by Geographical Region 2000-2005
- Figure 5-4: The Global Market for Prescription Antiaging and Photodamage
Drugs, Revenues by Geographical Region 2000-2010
- Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share
by Geographical Region 2005
- Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share
by Geographical Region 2010
- Table 5-16: Global Market for Prescription Antiaging and Photodamage
Drugs Revenues and Market Share by Supplier 2005
- Figure 5-7: Global Market for Prescription Antiaging and Photodamage
Drugs, Market Share by Leading Supplier 2005
- Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Table 6-1: Common Prescription Topical Corticosteroid Preparations
- Table 6-2: Common Prescription Systemic Corticosteroids
- Table 6-3: Prescription Dermatitis Formulations in Development
- Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea
Drugs by Type 2000-2010
- Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Revenues by Type 2000-2010
- Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Type 2005
- Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Type 2010
- Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea
Drugs by Geographical Region 2000-2010
- Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Revenues by Geographical Region 2000-2010
- Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Geographical Region 2005
- Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Geographical Region 2010
- Table 6-12: Global Market for Prescription Dermatitis and Seborrhea
Drugs Revenues and Market Share by Supplier 2005
- Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea
Drugs Market Share by Leading Supplier 2005
- Chapter Seven: Prescription Antifungal Drugs
- Table 7-1: Common Prescription Systemic Antifungal Dermatological
Formulations
- Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
- Table 7-3: Prescription Antifungal Dermatological Drugs in Development
- Table 7-4: The Global Market for Prescription Antifungal Dermatological
Drugs by Type 2000-2010
- Figure 7-1: The Global Market for Prescription Antifungal Dermatological
Drugs Revenues by Type 2000-2010
- Figure 7-2: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Type 2005
- Figure 7-3: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Type 2010
- Table 7-6: The Global Market for Prescription Antifungal Dermatological
Drugs by Geographical Region 2000-2005
- Figure 7-4: The Global Market for Prescription Antifungal Dermatological
Drugs Revenues by Geographical Region 2000-2005
- Figure 7-5: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Geographical Region 2005
- Figure 7-6: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Geographical Region 2010
- Table 7-12: Global Market for Prescription Antifungal Dermatological
Drugs Revenues and Market Share by Supplier 2005
- Figure 7-7: Global Market for Prescription Antifungal Dermatological
- Drugs Market Share by Leading Supplier 2005
- Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
- Table 8-2: Prescription Hair Loss or Hair Removal Formulations in
Development
- Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal
Drugs by Type 2000-2010
- Figure 8-1: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Type 2000-2010
- Figure 8-2: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2005
- Figure 8-3: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2010
- Table 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2000-2010
- Figure 8-4: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2000-2010
- Figure 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2005
- Figure 8-6: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2010
- Table 8-11: Global Market for Prescription Hair Loss and Hair Removal
Drugs Revenues and Market Share by Supplier 2005
- Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal
Drugs Market Share by Leading Supplier 2005
- Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Table 9-1: Common Prescription Hyperpigmentation/Melasma
- Formulations
- Table 9-2: Common Prescription Depigmenting Agents
- Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type
2000-2010
- Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs
Revenues by Type 2000-2010
- Figure 9-2: The Global Market for Prescription Hyperpigmentation/
Melasma Drugs, Share by Type 2005
- Figure 9-3: The Global Market for Prescription Hyperpigmentation/
Melasma Drugs Share by Type 2010
- Table 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs by Geographical Region 2000-2010
- Figure 9-4: The Global Market for Prescription Hyperpigmentation/
Melasma Drugs Revenues by Geographical Region 2000-2010
- Figure 9-5: The Global Market for Prescription Hyperpigmentation/
Melasma Drugs, Share by Geographical Region 2005
- Figure 9-6: The Global Market for Prescription Hyperpigmentation/
Melasma Drugs, Share by Geographical Region 2010
- Chapter Ten: Prescription Psoriasis Drugs
- Table 10-1: Common Prescription Psoriasis Preparations
- Table 10-2: Prescription Psoriasis Preparations in Development
- Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type
2000-2010
- Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues
by Type 2000-2010
- Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by
Type 2005
- Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by
Type 2010
- Table 10-5: The Global Market for Prescription Psoriasis Drugs by
Geographical Region 2000-2010
- Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues
by Geographical Region 2000-2010
- Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by
Geographical Region 2005
- Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by
Geographical Region 2010
- Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and
Market Share by Supplier 2005
- Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share
by Leading Supplier 2005
- Chapter Eleven: Prescription Skin Cancer Drugs
- Table 11-1: Malignant Conditions of the Skin
- Table 11-2: Common Prescription Topical and Intralesional
Chemotherapeutic Agents
- Table 11-3: Prescription Skin Cancer Preparations in Development
- Table 11-4: The Global Market for Skin Cancer Drugs 2000-2010
- Figure 11-1: The Global Market for Skin Cancer Drugs 2000-2010
- Table 11-5: The Global Market for Prescription Skin Cancer Drugs by
Geographical Region 1998-2008
- Figure 11-2: The Global Market for Prescription Skin Cancer Drugs
Revenues by Geographical Region 2000-2010
- Figure 11-3: The Global Market for Prescription Skin Cancer Drugs
- Share by Geographical Region 2005
- Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share
by Geographical Region 2010
- Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues
and Market Share by Supplier 2005
- Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading
Supplier 2005
- Chapter Twelve: Miscellaneous Skin Disorder Drugs--Antivirals and
Antiparasitics
- Table 12-1: Common Prescription Topical Antiviral Formulations
- Table 12-2: Common Prescription Topical Antiparasitic Formulations
- Table 12-3: The Global Market for Prescription Miscellaneous Skin
Disorder Drugs by Type 2000-2010
- Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs
Revenues by Type 2000-2005
- Table 12-5: The Global Market for Prescription Miscellaneous Drugs by
Geographical Region 2000-2010
- Figure 12-2: The Global Market for Prescription Miscellaneous Drugs
Revenues by Geographical Region 2000-2010
- Figure 12-3: The Global Market for Prescription Miscellaneous Drugs
Share by Geographical Region 2005
- Figure 12-6: The Global Market for Prescription Miscellaneous Drugs
Share by Geographical Region 2010
- Chapter Thirteen: World Market Summary
- Table 13-1: The Global Market for Prescription Dermatological Drugs,
Revenues by Segment, 2000-2010
- Figure 13-1: The Global Market for Prescription Dermatological Drugs
Revenues by Dermatological Segment, 2000-2010
- Figure 13-2: The Global Market for Dermatological Drugs Market Share by
Type 2005
- Figure 13-3: The Global Market for Prescription Dermatological Drugs
Market Share by Type 2010
- Table 13-3: Global Market for Prescription Dermatological Drugs Revenues
and Segments of Participation by Leading Market Participants 2005
|
Related Report
|
View Cart
